116 related articles for article (PubMed ID: 23155275)
1. c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors.
Choi JS; Seo J; Jung EJ; Kim EJ; Lee GK; Kim WH
Anticancer Res; 2012 Nov; 32(11):5031-7. PubMed ID: 23155275
[TBL] [Abstract][Full Text] [Related]
2. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma.
Jung EJ; Jung EJ; Min SY; Kim MA; Kim WH
Hum Pathol; 2012 Oct; 43(10):1559-66. PubMed ID: 22440694
[TBL] [Abstract][Full Text] [Related]
4. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.
Lee J; Seo JW; Jun HJ; Ki CS; Park SH; Park YS; Lim HY; Choi MG; Bae JM; Sohn TS; Noh JH; Kim S; Jang HL; Kim JY; Kim KM; Kang WK; Park JO
Oncol Rep; 2011 Jun; 25(6):1517-24. PubMed ID: 21424128
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.
Zhang M; Zhu GY; Zhang HF; Gao HY; Han XF; Xue YW
J Surg Oncol; 2010 Jul; 102(1):64-7. PubMed ID: 20578080
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathology and prognosis of mucinous gastric carcinoma.
Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction.
Kim MA; Jung EJ; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
Hum Pathol; 2007 Sep; 38(9):1386-93. PubMed ID: 17555797
[TBL] [Abstract][Full Text] [Related]
9. Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer.
Yoshida S; Matsumoto K; Arao T; Taniguchi H; Goto I; Hanafusa T; Nishio K; Yamada Y
Anticancer Res; 2013 Feb; 33(2):469-75. PubMed ID: 23393338
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of early-stage mucinous gastric carcinoma.
Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
[TBL] [Abstract][Full Text] [Related]
11. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
12. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
13. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis.
Park KU; Lee HE; Park DJ; Jung EJ; Song J; Kim HH; Choe G; Kim WH; Lee HS
Clin Chem Lab Med; 2009; 47(5):530-6. PubMed ID: 19302034
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features of mucinous gastric carcinoma.
Lim SW; Kim DY; Kim YJ; Kim SK
Dig Surg; 2002; 19(4):286-90. PubMed ID: 12207072
[TBL] [Abstract][Full Text] [Related]
15. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
16. A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis.
Wu CY; Yeh HZ; Shih RT; Chen GH
Cancer; 1998 Oct; 83(7):1312-8. PubMed ID: 9762931
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
18. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
[TBL] [Abstract][Full Text] [Related]
19. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma.
Calcagno DQ; Leal MF; Taken SS; Assumpção PP; Demachki S; Smith Mde A; Burbano RR
Anticancer Res; 2005; 25(6B):4069-74. PubMed ID: 16309200
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
